Cargando…
Clinical implication of minimal presence of solid or micropapillary subtype in early‐stage lung adenocarcinoma
BACKGROUND: We investigated the clinical features and surgical outcomes of lung adenocarcinoma with minimal solid or micropapillary (S/MP) components, with a focus on stage IA. METHODS: We enrolled 506 patients with lung adenocarcinoma who underwent curative resection in this study. Clinical feature...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812076/ https://www.ncbi.nlm.nih.gov/pubmed/33231358 http://dx.doi.org/10.1111/1759-7714.13754 |
_version_ | 1783637591904485376 |
---|---|
author | Choi, Sun Ha Jeong, Ji Yun Lee, Shin Yup Shin, Kyung Min Jeong, Shin Young Park, Tae‐In Do, Young Woo Lee, Eung Bae Seok, Yangki Lee, Won Kee Park, Ji Eun Park, Sunji Lee, Yong Hoon Seo, Hyewon Yoo, Seung Soo Lee, Jaehee Cha, Seung‐Ick Kim, Chang Ho Park, Jae Yong |
author_facet | Choi, Sun Ha Jeong, Ji Yun Lee, Shin Yup Shin, Kyung Min Jeong, Shin Young Park, Tae‐In Do, Young Woo Lee, Eung Bae Seok, Yangki Lee, Won Kee Park, Ji Eun Park, Sunji Lee, Yong Hoon Seo, Hyewon Yoo, Seung Soo Lee, Jaehee Cha, Seung‐Ick Kim, Chang Ho Park, Jae Yong |
author_sort | Choi, Sun Ha |
collection | PubMed |
description | BACKGROUND: We investigated the clinical features and surgical outcomes of lung adenocarcinoma with minimal solid or micropapillary (S/MP) components, with a focus on stage IA. METHODS: We enrolled 506 patients with lung adenocarcinoma who underwent curative resection in this study. Clinical features and surgical outcomes were compared between the groups with and without the S/MP subtype (S/MP+ and S/MP−, respectively), and between the group with an S/MP proportion of ≤5% (S/MP5) and the S/MP−. RESULTS: The S/MP subtype was present in 247 patients (48.8%); 129 (25.5%) were grouped as the S/MP5 group. The S/MP+ and S/MP5 groups had larger tumors, higher frequency of lymph node metastasis, and more advanced stages of disease than the S/MP− group (P < 0.001, all comparisons). Pleural, lymphatic, and vascular invasions occurred more frequently in the S/MP+ and S/MP5 groups (P < 0.001, all comparisons for S/MP+ vs. S/MP−; P ≤ 0.01, all comparisons for S/MP5 vs. S/MP−). The S/MP+ and S/MP5 groups showed a shorter time to recurrence and cancer‐related death than the S/MP− group(P < 0.001, both comparisons). For stage I, the presence or absence of the S/MP subtype defined prognostic subgroups better than the stage IA/IB classification. Notably, in the multivariate analysis, the minimal S/MP component was a significant predictor of recurrence, even in stage IA. CONCLUSIONS: The presence of the minimal S/MP component was a significant predictor of poor prognosis after surgery, even in stage IA patients. Clinical trials to evaluate the advantages of adjuvant chemotherapy for this subset of patients and further investigations to understand underlying biological mechanisms of poor prognosis are needed. KEY POINTS: Significant findings of the study: We demonstrated that only minimal presence of solid or micropapillary component was profoundly associated with aggressive clinicopathological features and poor prognosis after complete resection even in stage IA lung adenocarcinoma. What this study adds: Our results suggest that minimal presence of these subtypes is a strong prognostic factor which should be taken into account in the risk assessment for adjuvant chemotherapy in lung adenocarcinoma. |
format | Online Article Text |
id | pubmed-7812076 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley & Sons Australia, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-78120762021-01-22 Clinical implication of minimal presence of solid or micropapillary subtype in early‐stage lung adenocarcinoma Choi, Sun Ha Jeong, Ji Yun Lee, Shin Yup Shin, Kyung Min Jeong, Shin Young Park, Tae‐In Do, Young Woo Lee, Eung Bae Seok, Yangki Lee, Won Kee Park, Ji Eun Park, Sunji Lee, Yong Hoon Seo, Hyewon Yoo, Seung Soo Lee, Jaehee Cha, Seung‐Ick Kim, Chang Ho Park, Jae Yong Thorac Cancer Original Articles BACKGROUND: We investigated the clinical features and surgical outcomes of lung adenocarcinoma with minimal solid or micropapillary (S/MP) components, with a focus on stage IA. METHODS: We enrolled 506 patients with lung adenocarcinoma who underwent curative resection in this study. Clinical features and surgical outcomes were compared between the groups with and without the S/MP subtype (S/MP+ and S/MP−, respectively), and between the group with an S/MP proportion of ≤5% (S/MP5) and the S/MP−. RESULTS: The S/MP subtype was present in 247 patients (48.8%); 129 (25.5%) were grouped as the S/MP5 group. The S/MP+ and S/MP5 groups had larger tumors, higher frequency of lymph node metastasis, and more advanced stages of disease than the S/MP− group (P < 0.001, all comparisons). Pleural, lymphatic, and vascular invasions occurred more frequently in the S/MP+ and S/MP5 groups (P < 0.001, all comparisons for S/MP+ vs. S/MP−; P ≤ 0.01, all comparisons for S/MP5 vs. S/MP−). The S/MP+ and S/MP5 groups showed a shorter time to recurrence and cancer‐related death than the S/MP− group(P < 0.001, both comparisons). For stage I, the presence or absence of the S/MP subtype defined prognostic subgroups better than the stage IA/IB classification. Notably, in the multivariate analysis, the minimal S/MP component was a significant predictor of recurrence, even in stage IA. CONCLUSIONS: The presence of the minimal S/MP component was a significant predictor of poor prognosis after surgery, even in stage IA patients. Clinical trials to evaluate the advantages of adjuvant chemotherapy for this subset of patients and further investigations to understand underlying biological mechanisms of poor prognosis are needed. KEY POINTS: Significant findings of the study: We demonstrated that only minimal presence of solid or micropapillary component was profoundly associated with aggressive clinicopathological features and poor prognosis after complete resection even in stage IA lung adenocarcinoma. What this study adds: Our results suggest that minimal presence of these subtypes is a strong prognostic factor which should be taken into account in the risk assessment for adjuvant chemotherapy in lung adenocarcinoma. John Wiley & Sons Australia, Ltd 2020-11-24 2021-01 /pmc/articles/PMC7812076/ /pubmed/33231358 http://dx.doi.org/10.1111/1759-7714.13754 Text en © 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Choi, Sun Ha Jeong, Ji Yun Lee, Shin Yup Shin, Kyung Min Jeong, Shin Young Park, Tae‐In Do, Young Woo Lee, Eung Bae Seok, Yangki Lee, Won Kee Park, Ji Eun Park, Sunji Lee, Yong Hoon Seo, Hyewon Yoo, Seung Soo Lee, Jaehee Cha, Seung‐Ick Kim, Chang Ho Park, Jae Yong Clinical implication of minimal presence of solid or micropapillary subtype in early‐stage lung adenocarcinoma |
title | Clinical implication of minimal presence of solid or micropapillary subtype in early‐stage lung adenocarcinoma |
title_full | Clinical implication of minimal presence of solid or micropapillary subtype in early‐stage lung adenocarcinoma |
title_fullStr | Clinical implication of minimal presence of solid or micropapillary subtype in early‐stage lung adenocarcinoma |
title_full_unstemmed | Clinical implication of minimal presence of solid or micropapillary subtype in early‐stage lung adenocarcinoma |
title_short | Clinical implication of minimal presence of solid or micropapillary subtype in early‐stage lung adenocarcinoma |
title_sort | clinical implication of minimal presence of solid or micropapillary subtype in early‐stage lung adenocarcinoma |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812076/ https://www.ncbi.nlm.nih.gov/pubmed/33231358 http://dx.doi.org/10.1111/1759-7714.13754 |
work_keys_str_mv | AT choisunha clinicalimplicationofminimalpresenceofsolidormicropapillarysubtypeinearlystagelungadenocarcinoma AT jeongjiyun clinicalimplicationofminimalpresenceofsolidormicropapillarysubtypeinearlystagelungadenocarcinoma AT leeshinyup clinicalimplicationofminimalpresenceofsolidormicropapillarysubtypeinearlystagelungadenocarcinoma AT shinkyungmin clinicalimplicationofminimalpresenceofsolidormicropapillarysubtypeinearlystagelungadenocarcinoma AT jeongshinyoung clinicalimplicationofminimalpresenceofsolidormicropapillarysubtypeinearlystagelungadenocarcinoma AT parktaein clinicalimplicationofminimalpresenceofsolidormicropapillarysubtypeinearlystagelungadenocarcinoma AT doyoungwoo clinicalimplicationofminimalpresenceofsolidormicropapillarysubtypeinearlystagelungadenocarcinoma AT leeeungbae clinicalimplicationofminimalpresenceofsolidormicropapillarysubtypeinearlystagelungadenocarcinoma AT seokyangki clinicalimplicationofminimalpresenceofsolidormicropapillarysubtypeinearlystagelungadenocarcinoma AT leewonkee clinicalimplicationofminimalpresenceofsolidormicropapillarysubtypeinearlystagelungadenocarcinoma AT parkjieun clinicalimplicationofminimalpresenceofsolidormicropapillarysubtypeinearlystagelungadenocarcinoma AT parksunji clinicalimplicationofminimalpresenceofsolidormicropapillarysubtypeinearlystagelungadenocarcinoma AT leeyonghoon clinicalimplicationofminimalpresenceofsolidormicropapillarysubtypeinearlystagelungadenocarcinoma AT seohyewon clinicalimplicationofminimalpresenceofsolidormicropapillarysubtypeinearlystagelungadenocarcinoma AT yooseungsoo clinicalimplicationofminimalpresenceofsolidormicropapillarysubtypeinearlystagelungadenocarcinoma AT leejaehee clinicalimplicationofminimalpresenceofsolidormicropapillarysubtypeinearlystagelungadenocarcinoma AT chaseungick clinicalimplicationofminimalpresenceofsolidormicropapillarysubtypeinearlystagelungadenocarcinoma AT kimchangho clinicalimplicationofminimalpresenceofsolidormicropapillarysubtypeinearlystagelungadenocarcinoma AT parkjaeyong clinicalimplicationofminimalpresenceofsolidormicropapillarysubtypeinearlystagelungadenocarcinoma |